Facebook Linkedin Twitter
Inside Precision Medicine Disrupting Cancer Cells’ Oxygen Adaptation as New Anti-Cancer Target

GlaxoSmithKline

cancer development
News & Features

Disrupting Cancer Cells’ Oxygen Adaptation as New Anti-Cancer Target

0
Artificial intelligence DNA
News & Features

“Ground-Breaking” Release of World’s Largest Whole Genome Resource

0
Pipette Petri Dish DNA
News & Features

Bridging Gaps for Affordable Cell and Gene Therapies: Overcoming Financial and Systematic Obstacles

William A. Haseltine, PhD
0
Human Respiratory System Lungs Anatomy
News & Features

GSK acquires BELLUS Health and P2X3 Antagonist for $2 Billion

0
Human bone marrow under the microscope to illustrate myelofibrosis blood cancer, the diagnosis of which could be aided by new AI tools
News & Features

Momelotinib Performs Well at Phase III in Rare Bone Marrow Cancer Patients

0
Meeting handshake
News & Features

Pol Theta Helicase Development Deal with GSK Has Potential to Add Nearly $1 Billion to Ideaya Bio’s Coffers

0
CART Cell Cancer Immunotherapy
News & Features

GSK’s Jemperli Delivers 100% Response in Rectal Cancer

0
Cancer cells
News & Features

GSK Acquires Targeted Cancer Company Sierra Oncology for $1.9B

0
cancer
Molecular Dx

MRD: The Future Foundation of Solid Tumor Trials

Laura Cowen
0
A conceptual illustration of Fatty liver cells in the shape of a liver to represent non-alcoholic fatty liver disease.
News & Features

GSK, PathAI Ink Oncology, NASH Research Partnership

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine